Chlorpyrifos Doubles Parkinson's Risk | UCLA Study
UCLA researchers reveal chlorpyrifos exposure elevates Parkinson's risk over 2.5-fold, blending epidemiology and animal models for causal evidence.
No reviews yet. Be the first to rate Jeff!
Jeff M. Bronstein is a Professor of Neurology and Molecular Toxicology at the University of California, Los Angeles. He received his bachelor’s degree from the University of California, Berkeley and his M.D. and Ph.D. from UCLA as a recipient of the Medical Scientist Training Program Award. He completed a residency in Neurology and fellowship training in Movement Disorders at UCLA, as well as a postdoctoral fellowship in molecular biology. He was appointed Assistant Professor of Neurology before being named Director of the UCLA Movement Disorders Program and Professor of Neurology and Molecular Toxicology. He holds the Fred Silton Family Chair in Movement Disorders.
Dr. Bronstein’s expertise centers on the management of Parkinson’s disease and other movement disorders, including surgical treatments and the development of new therapies. His laboratory studies the causes of Parkinson’s disease using cell models and a zebrafish model, with research support from the NIH and private foundations. He directs clinical trials focused on therapies such as transplantation and deep brain stimulation. He was awarded one of six National Parkinson’s Disease Centers at the Veterans Administration Medical Center to advance research, education, and clinical care in the Southwest United States. Dr. Bronstein has received several awards, including Super Doctors recognition in Southern California for multiple years, and is widely published in his field.
UCLA researchers reveal chlorpyrifos exposure elevates Parkinson's risk over 2.5-fold, blending epidemiology and animal models for causal evidence.